In USA approved drug that acts as female viagra

В США одобрен препарат, действующий как женская виагра

This drug is available under the trademark Vyleesi, also known as bremelanotide. Recently it was approved for mass production American management under the control over products and medicines FDA.

FDA approved for use the drug is designed for women in premenopausal women with reduced libido, – this was reported by the portal, Science Alert. Interestingly, the Agency is well aware of: the new female viagra has only a “meager peer-reviewed data.”

Developed by AMAG Pharmaceuticals drug Vyleesi will be produced in the form of a single syringe for self-injection. It is necessary to enter in the thigh or abdomen somewhere 45 minutes before the expected sexual intercourse. In the absence of impact of regular use of the drug for 8 weeks, the introduction of tools should be discontinued.

Experts say that reduced sexual desire is common among women in premenopausal women a violation. It is assumed that the reason for this phenomenon is of a neurological nature. Established women’s Vihara able to exert a stimulating effect on melanocortin receptors, but at the same time, the FDA specifies: the mechanisms of influence created by the drug on libido is not completely clear.

The efficacy and safety of Vyleesi was studied in two 24-week randomized, double-blind, placebo-controlled studies in more than 1200 women in premenopausal women with HSDD. Some experts believe that this is not enough for approval of the drug for release. In addition, they note, the reasons of women reluctance sex can be all sorts of reasons, not only physiological.

Share